MANAGING CHRONIC ATRIAL-FIBRILLATION - A MARKOV DECISION-ANALYSIS COMPARING WARFARIN, QUINIDINE, AND LOW-DOSE AMIODARONE

被引:70
作者
DISCH, DL
GREENBERG, ML
HOLZBERGER, PT
MALENKA, DJ
BIRKMEYER, JD
机构
[1] DEPT VET AFFAIRS MED CTR, WHITE RIVER JCT, VT USA
[2] DARTMOUTH HITCHCOK CHRON MED CTR, LEBANON, NH USA
关键词
ATRIAL FIBRILLATION; DECISION-SUPPORT TECHNIQUES; AMIODARONE; QUINIDINE; WARFARIN;
D O I
10.7326/0003-4819-120-6-199403150-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To compare the relative risks and benefits of several clinical strategies for managing patients with chronic atrial fibrillation. Design: Five recent randomized controlled trials of warfarin in atrial fibrillation, 6 randomized controlled trials of quinidine, and 13 longitudinal studies of low-dose amiodarone were used. A MEDLINE search was also done (1966 to present). Measurements: A Markov decision analysis model was used to assess outcomes in large, hypothetical cohorts of patients with atrial fibrillation followed from 65 to 70 years of age within four clinical strategies: 1) no treatment; 2) warfarin; 3) electrical cardioversion followed by quinidine to maintain normal sinus rhythm; and 4) electrical cardioversion followed by low-dose amiodarone. Results: In this hypothetical cohort, fewer patients had disabling events with amiodarone (1.4%) than with quinidine (1.8%), warfarin (2.6%), or no treatment (7.4%). Amiodarone appeared to be associated with the lowest 5-year mortality (13.6%) when compared with warfarin (14.4%), quinidine (15.2%), and no treatment (18.2%). In terms of quality-adjusted life-years, amiodarone had the highest expected value (4.75 years), followed by warfarin (4.72 years), quinidine (4.68 years), and no treatment (4.55 years). Amiodarone remained the preferred strategy using the most plausible scenarios of risks associated with atrial fibrillation. Choices among warfarin, quinidine, and no treatment depended on estimates of bleeding rates with warfarin, stroke rates after discontinuing warfarin, quinidine-related mortality, and the quality of life with warfarin. Conclusion: Cardioversion followed by low-dose amiodarone to maintain normal sinus rhythm appears to be a relatively safe and effective treatment for patients with chronic atrial fibrillation.
引用
收藏
页码:449 / 457
页数:9
相关论文
共 78 条
[1]   STROKE PREVENTION IN NONVALVULAR ATRIAL-FIBRILLATION [J].
ALBERS, GW ;
ATWOOD, JE ;
HIRSH, J ;
SHERMAN, DG ;
HUGHES, RA ;
CONNOLLY, SJ .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (09) :727-736
[2]  
ANDERSON DC, 1992, ANN INTERN MED, V116, P6
[3]   ROLE OF PROPHYLACTIC ANTICOAGULATION FOR DIRECT-CURRENT CARDIOVERSION IN PATIENTS WITH ATRIAL-FIBRILLATION OR ATRIAL-FLUTTER [J].
ARNOLD, AZ ;
MICK, MJ ;
MAZUREK, RP ;
LOOP, FD ;
TROHMAN, RG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (04) :851-855
[4]   A PROSPECTIVE-STUDY OF ACUTE CEREBROVASCULAR-DISEASE IN THE COMMUNITY - THE OXFORDSHIRE COMMUNITY STROKE PROJECT 1981-86 .2. INCIDENCE, CASE FATALITY RATES AND OVERALL OUTCOME AT ONE YEAR OF CEREBRAL INFARCTION, PRIMARY INTRACEREBRAL AND SUBARACHNOID HEMORRHAGE [J].
BAMFORD, J ;
SANDERCOCK, P ;
DENNIS, M ;
BURN, J ;
WARLOW, C .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (01) :16-22
[5]  
Beck J R, 1981, Med Decis Making, V1, P285, DOI 10.1177/0272989X8100100309
[6]   THE MARKOV PROCESS IN MEDICAL PROGNOSIS [J].
BECK, JR ;
PAUKER, SG .
MEDICAL DECISION MAKING, 1983, 3 (04) :419-458
[7]   THE COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS BLOOD DONATION FOR TOTAL HIP AND KNEE REPLACEMENT [J].
BIRKMEYER, JD ;
GOODNOUGH, LT ;
AUBUCHON, JP ;
NOORDSIJ, PG ;
LITTENBERG, B .
TRANSFUSION, 1993, 33 (07) :544-551
[8]   EFFICACY OF ANTICOAGULANT THERAPY IN PREVENTING EMBOLISM RELATED TO DC ELECTRICAL CONVERSION OF ATRIAL FIBRILLATION [J].
BJERKELUND, CJ ;
ORNING, OM .
AMERICAN JOURNAL OF CARDIOLOGY, 1969, 23 (02) :208-+
[9]   AMIODARONE IN THE MANAGEMENT OF REFRACTORY ATRIAL-FIBRILLATION [J].
BLEVINS, RD ;
KERIN, NZ ;
BENADERET, D ;
FRUMIN, H ;
FAITEL, K ;
JARANDILLA, R ;
RUBENFIRE, M .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (08) :1401-1404
[10]  
Boissel J P, 1981, Eur Heart J, V2, P49